Display options
Share it on

Int J Hepatol. 2012;2012:487480. doi: 10.1155/2012/487480. Epub 2012 Jul 03.

Acute Liver Failure Caused by Amanita phalloides Poisoning.

International journal of hepatology

Luca Santi, Caterina Maggioli, Marianna Mastroroberto, Manuel Tufoni, Lucia Napoli, Paolo Caraceni

Affiliations

  1. U.O. Semeiotica Medica, Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, Via Albertoni 15, 40138 Bologna, Italy.

PMID: 22811920 PMCID: PMC3395149 DOI: 10.1155/2012/487480

Abstract

Mushroom poisoning is a relatively rare cause of acute liver failure (ALF). The present paper analyzes the pathogenesis, clinical features, prognostic indicators, and therapeutic strategies of ALF secondary to ingestion of Amanita phalloides, which represents the most common and deadly cause of mushroom poisoning. Liver damage from Amanita phalloides is related to the amanitins, powerful toxins that inhibit RNA polymerase II resulting in a deficient protein synthesis and cell necrosis. After an asymptomatic lag phase, the clinical picture is characterized by gastrointestinal symptoms, followed by the liver and kidney involvement. Amatoxin poisoning may progress into ALF and eventually death if liver transplantation is not performed. The mortality rate after Amanita phalloides poisoning ranges from 10 to 20%. The management of amatoxin poisoning consists of preliminary medical care, supportive measures, detoxification therapies, and orthotopic liver transplantation. The clinical efficacy of any modality of treatment is difficult to demonstrate since randomized, controlled clinical trials have not been reported. The use of extracorporeal liver assist devices as well as auxiliary liver transplantation may represent additional therapeutic options.

References

  1. Swiss Med Wkly. 2001 Oct 20;131(41-42):616-7 - PubMed
  2. J Hepatol. 2005 Feb;42(2):202-9 - PubMed
  3. Virchows Arch B Cell Pathol. 1978 Jul 14;28(1):13-20 - PubMed
  4. Hum Exp Toxicol. 2010 Oct;29(10):823-32 - PubMed
  5. Crit Care Med. 1985 May;13(5):402-6 - PubMed
  6. N Engl J Med. 1979 Apr 5;300(14):800 - PubMed
  7. Liver Int. 2003;23 Suppl 3:28-33 - PubMed
  8. J Hepatol. 1993 Nov;19(3):486-7 - PubMed
  9. J Am Soc Nephrol. 2001 Feb;12 Suppl 17:S75-82 - PubMed
  10. Gastroenterology. 1997 Mar;112(3):923-34 - PubMed
  11. Compr Ther. 1982 Dec;8(12):33-9 - PubMed
  12. J Toxicol Clin Toxicol. 2002;40(6):715-57 - PubMed
  13. Clin Toxicol (Phila). 2011 Nov;49(9):782-93 - PubMed
  14. Arch Microbiol. 1978 Sep 1;118(3):317-9 - PubMed
  15. Hum Toxicol. 1988 Mar;7(2):199-201 - PubMed
  16. Hum Exp Toxicol. 1994 Aug;13(8):542-4 - PubMed
  17. Br J Clin Pharmacol. 2001 Jan;51(1):87-91 - PubMed
  18. Hum Toxicol. 1983 Apr;2(2):183-95 - PubMed
  19. Am J Med. 1975 Apr;58(4):505-9 - PubMed
  20. Am J Gastroenterol. 2001 Nov;96(11):3195-8 - PubMed
  21. Arch Toxicol. 1985 Jan;56(3):190-4 - PubMed
  22. J Emerg Med. 2005 Jan;28(1):53-62 - PubMed
  23. J Hepatol. 2004 Jul;41(1):152-5 - PubMed
  24. Gastroenterology. 1989 Aug;97(2):439-45 - PubMed
  25. Arzneimittelforschung. 1980;30(3):452-4 - PubMed
  26. Klin Wochenschr. 1979 Nov 2;57(21):1143-52 - PubMed
  27. Toxicon. 1998 Jan;36(1):13-24 - PubMed
  28. Mycopathologia. 1989 Feb;105(2):99-110 - PubMed
  29. J Toxicol Clin Toxicol. 1993;31(1):63-80 - PubMed
  30. Lancet. 1977 May 21;1(8021):1111 - PubMed
  31. Ann Pharmacother. 2004 Mar;38(3):498-500 - PubMed
  32. Toxicon. 2003 Sep 15;42(4):339-49 - PubMed
  33. J Hepatol. 2007 Mar;46(3):466-73 - PubMed
  34. J Hepatol. 2005 Feb;42(2):166-9 - PubMed
  35. Toxicon. 1993 Dec;31(12):1513-40 - PubMed
  36. J Toxicol Clin Toxicol. 2004;42(6):901-12 - PubMed

Publication Types